Limaros Tablet (Limaprost Alfa-Dex)

Adult dose

1. For improvement of ischemic symptoms such as ulcers, pain, and coldness caused by thromboangiitis obliterans (Buerger's disease), the usual adult dose is 2 tablets orally 3 times daily. 2. For improvement of subjective symptoms (leg pain and leg numbness) and walking ability caused by acquired lumbar spinal canal stenosis (in patients with a normal SLR test and bilateral intermittent claudication), the usual adult dose is 1 tablet orally 3 times daily. Adjust the dose as appropriate according to age and symptoms.

This medicine should not be used in women who are pregnant or may become pregnant. This medicine contains lactose and should not be given to patients with genetic disorders that result in lactose intolerance. It should be used with caution in patients with a risk of bleeding or those taking medications that affect blood coagulability. Hypersensitive reactions such as skin rashes or itching may occur while using this medicine; if such symptoms arise, use should be discontinued immediately. Bleeding may occur infrequently, so symptoms should be carefully monitored, and administration should be stopped if abnormalities are present. This medication may affect the gastrointestinal tract, leading to symptoms such as diarrhea, nausea, abdominal pain, decreased appetite, and heartburn. Since it may affect liver function and increase liver enzyme levels, it is advisable to periodically check liver status. Be cautious as it may cause an increased heart rate, and in rare cases, fingers and toes may turn blue or blood pressure may drop. Symptoms such as headache, facial flushing, dizziness, warmth, general fatigue, and swelling may occur. Patients with lumbar spinal stenosis should carefully monitor their symptoms and decide whether to continue using this medication. The effectiveness of this drug is not guaranteed in severe cases that require spinal surgery. Safety during pregnancy is not established, and it should not be used in pregnant women due to reported uterine contraction effects in animal studies. Safety for children has not been verified, so it is advisable not to use it in children. Elderly individuals may have reduced physical function, so use should be cautious, including dose reductions.

• Rash
• itching
• bleeding
• diarrhea
• nausea
• abdominal discomfort
• abdominal pain
• loss of appetite
• heartburn
• vomiting

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.

Appearance

White round tablet

Package unit

84 tablets (21 tablets/PTP x 4)